Sotera Health Co.

As of October 10, 2025, Sotera Health Co. shows a mildly bullish trend with positive MACD and Bollinger Bands, despite some caution from Dow Theory, having outperformed the S&P 500 year-to-date but lagged over the past year.

As of October 10, 2025, Sotera Health Co. shows a mildly bullish trend with positive momentum indicators, but mixed signals suggest caution due to some selling pressure, while year-to-date performance outpaces the S&P 500.

As of October 10, 2025, Sotera Health Co. shows a mildly bullish trend supported by positive MACD and Bollinger Bands, despite bearish signals from Dow Theory and OBV, while underperforming the S&P 500 recently but outperforming it year-to-date and over three years.

As of August 28, 2025, Sotera Health Co. is in a bullish trend supported by positive indicators like a bullish MACD and moving averages, despite a bearish weekly RSI and underperformance over the past year compared to the S&P 500.

As of July 7, 2025, Sotera Health Co. is considered very expensive with a P/E ratio of 36 and has underperformed the S&P 500 by -4.6% over the past year, indicating significant overvaluation compared to its peers.

As of February 27, 2025, Sotera Health Co. is considered overvalued with a P/E ratio of 36 compared to the industry average of 14.54, and despite respectable performance metrics, its stock has underperformed the S&P 500 by 18.93% year-to-date.

As of June 18, 2025, Sotera Health Co. is in a bearish trend with moderate strength, driven by bearish signals from moving averages and Bollinger Bands, despite some mildly bullish indicators in the short term.

Sotera Health Co. is a small-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $255 million and a net profit of -$13 million. It has a market cap of $3.14 billion and key metrics include a P/E ratio of 36.00 and a debt-to-equity ratio of 4.64.

As of Jun 18, Sotera Health Co. has a market capitalization of $3.14 billion, with net sales of $1.11 billion and a net profit of $24.80 million for the latest four quarters. The balance sheet shows shareholder's funds of $404.91 million and total assets of $3.19 billion.